Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Clinical Trial to Evaluate the Biological Activity of HDAC (Histone Deacetylase Transferases) Inhibition on ER and PR Expression in Triple Negative Invasive Breast Cancer

NCT01695057 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT01695057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01695057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Clinical Trial to Evaluate the Biological Activity of HDAC (Histone Deacetylase Transferases) Inhibition on ER and PR Expression in Triple Negative Invasive Breast Cancer
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Withdrawn
Start date
October 31, 2012
Completion date
October 31, 2015
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii breast cancer, stage iiia breast cancer, triple-negative breast cancer